Clinical Trials Logo

Prurigo Nodularis clinical trials

View clinical trials related to Prurigo Nodularis.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05061693 Active, not recruiting - Prurigo Nodularis Clinical Trials

A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

Start date: November 4, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of INCB054707 in participants with prurigo nodularis over a 16-week double-blind placebo-controlled treatment period, followed by a 24 -week single blind extension period.

NCT ID: NCT04204616 Active, not recruiting - Prurigo Nodularis Clinical Trials

A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Start date: January 11, 2021
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to assess the long-term safety of nemolizumab (CD14152) in participants with prurigo nodularis (PN).